Connection

Robert Gemmill to Antineoplastic Combined Chemotherapy Protocols

Back to Details
This is a "connection" page, showing publications Robert Gemmill has written about Antineoplastic Combined Chemotherapy Protocols.
Robert Gemmill
Connection Strength
0.075
Antineoplastic Combined Chemotherapy Protocols
  1. Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination. Invest New Drugs. 2012 Dec; 30(6):2303-17.
    View in: PubMed
    Score: 0.075
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.